AI Summary & Key Takeaways
AI InsightMore emphasis should be placed on the importance of vaccination against COVID-19, especially in elderly individuals receiving tuberculosis treatment.
📌 3 Key Takeaways
Abstract
Tuberculosis was the leading cause of death worldwide before COVID-19. The present study aimed to examine the cases of COVID-19 disease and vaccination against COVID-19 in patients receiving tuberculosis treatment in Sakarya. In this descriptive study, 132 people aged 18 years and over, registered in Sakarya Tuberculosis Dispensary and continuing treatment in 2021, were included. Cases of COVID-19, hospitalization, intensive care unit (ICU) status and vaccination status against COVID-19 were recorded. Statistical significance level was accepted as p<0.05. The mean age of the patients was 49.8±20.6 years. 65.2% of the patients were male (n=86). It has been determined that 21.2% (n=28) of the patients have been diagnosed with COVID19. No statistically significant difference was observed between the patients' gender and history of COVID-19 infection with mortality (p>0.05). There was no statistically significant difference between the ages of groups with and without COVID-19 (p>0.05). Age was statistically significantly different in the surviving and deceased groups (p<0.05). There was a statistically significant difference between the vaccination status of the patients and mortality (p<0.05).People being treated for tuberculosis are at risk as long as the danger of COVID-19 continues. More emphasis should be placed on the importance of vaccination against COVID-19, especially in elderly individuals receiving tuberculosis treatment.